FDA Adverse Event Injury Summary report: N

XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 3790811 · Received May 5, 2014

Report

Report Number
2024168-2014-02821
Event Type
Injury
Date Received
May 5, 2014
Date of Event
January 8, 2014
Report Date
April 12, 2014
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P110019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT PRODUCTS: DIL CATH: NC TREK (2.25X6, 2.25X15); OTHER: ASPIRIN. THERE WAS NO REPORTED DEVICE MALFUNCTION AND THE PRODUCT WAS NOT RETURNED. THE REPORTED PATIENT EFFECT OF DISSECTION, AS LISTED IN THE XIENCE XPEDITION, XIENCE XPEDITION SV, AND XIENCE XPEDTION LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM ELECTRONIC INSTRUCTIONS FOR USE, IS A KNOWN PATIENT EFFECT THAT MAY BE ASSOCIATED WITH USE OF A CORONARY STENT IN NATIVE CORONARY ARTERIES. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURING, DESIGN OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT THERE WAS UNSPECIFIED TREATMENT DONE IN A LEFT ANTERIOR DESCENDING ARTERY (LAD). A XIENCE XPEDITION STENT WAS IMPLANTED IN A 1ST LEFT POSTERIOR LATERAL ARTERY (LPL) AND A DISSECTION WAS SEEN REQUIRING ANOTHER UNPLANNED XIENCE XPEDITION 2.25 X 15 MM STENT TO BE IMPLANTED AS SUCCESSFUL TREATMENT. THERE WAS NO PROLONGED HOSPITALIZATION REPORTED. THE PATIENT WAS DISCHARGED HOME THE NEXT DAY. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
267680 XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 3092341

Patients

Seq Age Sex Outcome Treatment
1 63 YR Required Intervention CONCOMITANT MEDICAL DEVICES